CMS updates urine drug test edits; analyze the details

Why This Topic Matters

The update affects how certain urine drug testing claims are processed under Medicare and may influence whether claims are held, submitted, appealed, or later adjusted. Billing teams need to know the scope of the edit change and the implementation timeline so they can manage reimbursement workflows appropriately.

Article Sections

1. NCCI edit update for urine drug testing

   Summarizes a CMS change to Medicare editing policy for urine drug testing claims and the planned implementation timeline. The section frames the issue for laboratory and office billing workflows.

2. CMS notice text

   Presents the official notice language describing the edit update, retroactive timing, and claim-processing approach. It also references related Medicare contractor handling and appeals options.

3. Resource

   Provides a CMS reference link for replacement files related to Medicare NCCI edits.